Combined Injectable Treatment for HIV and OUD

NCT05991622 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study was initiated but no participants were enrolled.

Conditions

Human Immunodeficiency Virus
Opioid Use Disorder

Interventions

DRUG: Combined LAI Treatment: Cabenuva and Sublocade

Sponsor

Rhode Island Hospital